Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
Nature Immunology|November 9, 2023
Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infectionJason W Griffith, Lucas D Faustino, Victoria I Cottrell, et al.
Rheumatology (Oxford, England)|August 29, 2015
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritisUlrich A Walker, Veronika K Jaeger, Katerina Chatzidionysiou, et al.
Blood|September 13, 2012
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cellsSolenne Vigne, Gaby Palmer, Praxedis Martin, et al.
RMD Open|September 29, 2017
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumabGerd R Burmester, Gurjit S Kaeley, Arthur F Kavanaugh, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Cell Reports|February 15, 2018
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin SecretionMarianne Böni-Schnetzler, Stéphanie P Häuselmann, Elise Dalmas, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2017
ReplyScott W Canna, Charlotte Girard, Louise Malle, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2016
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibitionScott W Canna, Charlotte Girard, Louise Malle, et al.
Rheumatology (Oxford, England)|June 19, 2019
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolutionKim Lauper, Denis Mongin, Deshire Alpizar-Rodriguez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood BiomarkersChristoph Kessel, Richard Vollenberg, Katja Masjosthusmann, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
Nature Immunology|November 9, 2023
Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infectionJason W Griffith, Lucas D Faustino, Victoria I Cottrell, et al.
Rheumatology (Oxford, England)|August 29, 2015
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritisUlrich A Walker, Veronika K Jaeger, Katerina Chatzidionysiou, et al.
Blood|September 13, 2012
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cellsSolenne Vigne, Gaby Palmer, Praxedis Martin, et al.
RMD Open|September 29, 2017
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumabGerd R Burmester, Gurjit S Kaeley, Arthur F Kavanaugh, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Cell Reports|February 15, 2018
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin SecretionMarianne Böni-Schnetzler, Stéphanie P Häuselmann, Elise Dalmas, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2017
ReplyScott W Canna, Charlotte Girard, Louise Malle, et al.
The Journal of Allergy and Clinical Immunology|November 24, 2016
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibitionScott W Canna, Charlotte Girard, Louise Malle, et al.
Rheumatology (Oxford, England)|June 19, 2019
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolutionKim Lauper, Denis Mongin, Deshire Alpizar-Rodriguez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood BiomarkersChristoph Kessel, Richard Vollenberg, Katja Masjosthusmann, et al.
Pageof 26